Schrodinger

Pharmaceutical company · New York, United States · Nasdaq: SDGR

Schrodinger is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker SDGR. It has reported private securities offerings to the US SEC, most recently $108 million sold in a notice filed in 2019.

www.schrodinger.comProfile compiled from public records. Is this your company? Request a correction or update

Schrodinger at a glance

Typepharmaceutical company

HeadquartersNew York, United States

Stock listingNasdaq: SDGR

SEC industryPharmaceutical Preparations

SEC CIK1490978

What does Schrodinger do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $107.8 million sold (2019).

Schrodinger on the BioBridgeX marketplace

CRO · Target ID & Validation, Hit-to-Lead, Lead Optimization

Services

Target ID & ValidationHit-to-LeadLead OptimizationComputational / AI-Driven DiscoveryStructural Biology

Therapeutic areas

OncologyCNS / NeurologyImmunology & InflammationInfectious Disease

Modalities

Small MoleculeMonoclonal Antibody (mAb)PROTAC / Targeted Protein DegraderPeptide

Compare quotes

Unclaimed listing. Claim this profile

Frequently asked questions about Schrodinger

Where is Schrodinger headquartered?

Schrodinger is headquartered in New York, United States.

What does Schrodinger do?

Schrodinger is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Schrodinger a public company?

Yes. Schrodinger trades on Nasdaq under the ticker SDGR.

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.